QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 201 filers reported holding QIAGEN NV in Q1 2016. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $3,491,000 | -12.9% | 124,578 | -14.7% | 0.02% | -6.2% |
Q3 2016 | $4,008,000 | +23.5% | 146,070 | -1.8% | 0.02% | +23.1% |
Q2 2016 | $3,245,000 | -10.2% | 148,770 | -8.0% | 0.01% | -7.1% |
Q1 2016 | $3,614,000 | -22.5% | 161,770 | -4.1% | 0.01% | -22.2% |
Q4 2015 | $4,662,000 | +4.3% | 168,610 | -2.7% | 0.02% | +5.9% |
Q3 2015 | $4,470,000 | +1.3% | 173,240 | -2.7% | 0.02% | +13.3% |
Q2 2015 | $4,413,000 | -1.2% | 178,000 | +0.4% | 0.02% | 0.0% |
Q1 2015 | $4,468,000 | +4.6% | 177,290 | -2.7% | 0.02% | 0.0% |
Q4 2014 | $4,273,000 | +9.3% | 182,140 | +6.0% | 0.02% | +7.1% |
Q3 2014 | $3,911,000 | -6.2% | 171,750 | +0.7% | 0.01% | -6.7% |
Q2 2014 | $4,171,000 | +18.2% | 170,590 | +2.0% | 0.02% | +15.4% |
Q1 2014 | $3,528,000 | -11.3% | 167,280 | +0.1% | 0.01% | -13.3% |
Q4 2013 | $3,978,000 | +8.0% | 167,070 | -2.9% | 0.02% | 0.0% |
Q3 2013 | $3,683,000 | -0.2% | 172,080 | -7.2% | 0.02% | 0.0% |
Q2 2013 | $3,692,000 | – | 185,420 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hardman Johnston Global Advisors LLC | 6,178,402 | $170,833,000 | 11.32% |
Tikvah Management LLC | 369,425 | $10,215,000 | 5.35% |
BLUE JAY CAPITAL MANAGEMENT, LLC | 360,000 | $9,954,000 | 3.36% |
Opus Point Partners Management, LLC | 160,000 | $4,424,000 | 2.92% |
Exane Asset Management | 106,238 | $2,910,304,000 | 1.76% |
Douglas C. Lane & Associates, Inc. | 1,918,338 | $53,042,000 | 1.44% |
Granahan Investment Management | 1,051,000 | $29,060,000 | 1.00% |
CRAMER ROSENTHAL MCGLYNN LLC | 2,285,569 | $63,196,000 | 0.95% |
Sivik Global Healthcare LLC | 70,000 | $1,936,000 | 0.92% |
PURA VIDA INVESTMENTS, LLC | 78,668 | $2,175,000 | 0.92% |